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Introduction

This paper reviews the contrib uti on of
scanning electron mic roscopy (SEM)to our understanding of plate le t physi ol ogy and pathology.
Observat i ons of pl atelet shape changes which
accompany activat io n and the abi lit y to visualize
and analyze pl atelet aggregation and adhesion in
three dimensions make this exper i mental medium
an important tool in the evaluat ion of health y
and diseased plat el ets. Whil e SEMadds a
valuable third dimension to the study of morphol ogy and ultr astr uctur e, it s greatest contributi on is r ea li zed when st udi es are corr elated
dir ectly with light and/or transmission el ectron
mi croscop i c observat ion s and with st udies of
functiona l capacity.

Platelets are capabl e of activ i ties as
diverse as those seen in nucleated cells . They
adhere to surfaces (Hell em 1960, Michaeli and
Orl off 1976), undergo alterations in shape (Born
1970, White 1974b, Froj movic and Milt on 1982),
secrete granul e contents (Whit e 1970,1973),
interact with other platelet s to form aggregates
(Born and Cross 1963, Vargaftig et al . 1981),
mi grate directionally in re sponse to chemotacti c
si gnal s (Lowenhaupt 1982), engulf particles
(Movat et al . 1965, Mustard and Packham 1968,
Whit e 1972a), are capabl e of intern al contraction
(White 1974a), and express procoagul ant activ it y
(Walsh 1978) .
In the maintenance of hemostasi s , adhesion,
granul e re l ease ("the relea se reaction"),
aggregation, and contraction are considered the
basic plate l et reactions (White 1982). Whil e
they usuall y occur together, any one of these
functions can be expressed independently of the
others.
Adhesion refers to the interaction of platelets with surfaces.
Subendotheli al structures
including collagen and microf ib ri l s provide the
adhere nt surf aces during hemostasi s (Baumgartner
and Haudenschild 1972). In contrast, aggrega tion
refers to plat el et - pl at el et interactions.
The
combined effect of adhesion to subendothelial
str uctures and platelet-platelet
aggregation is
required for the formation of a competent pr i mary
hemostatic plug (Baumgartner and Muggli 1976).
Stimulat ion of the plate l et membraneby pl ate l et
agonists results in mobiliz at ion of arachido nic
acid for prostaglandin synthes i s. ThromboxaneA2
(TxA?) and cyclic endoperoxid e intermediates are
powerful aggregators and stimu li for granule
r el ease . They may act e ith er indir ect ly via
cyclic AMP(Salzman 1977, Smith 1981) or directly
as ionophores to mediate cal cium mobilization
(Gerrard and White 1978) . Calciu m mobilization
and prostaglandin (TxA?) synthesi s support cytoskeletal mediated internal contr act i on which is
responsible for central migration of granules and
microtubules following platelet stimulation and
which contributes to the shape change associated
with stimulation (Gerrard and White 1978) . In
addition, contraction potentiates granule
secretion and provides the forces for clot
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retraction,
a process that stabilizes the fibrinplatelet network that fonns during clott in g.
Granule secret i on enhances platelet plug formation by release of ADPand serotonin, two
powerful platelet agonists, from dense bodies
into the immediate environment of the evolving
aggregate, thus promoting its propagation
(Holmsen et al. 1969).

White and Clawson 1981, 1982). While large particle uptake does not appear to represent phagocytos i s (Whi te 1972a), small particle uptake is
associated with formation of phagolysosomes and
thus would appear to be true phagocytosis (Lewis
et al. 1976, Whi te and Clawson 1982).
The exterior coat or glycocalyx is formed by
the exterior projection of membrane glycoprote i ns
and glyco li pids. By negative stain whole mount
electron mi croscopy it has been defined as a
dense layer of 15-20 nm exterior to the trilaminar plasma membrane (Behnke 1967, 1968). Using
cationic dyes, White (1971b) demonstrated that
the platelet exterior coat is thicker and denser
than that present in other blood cells.
Despite
its external or i entation, the exterior coat is
not appreciated by conventiona l SEM
.
Polyacry lamide gel el ectrophoresis of isolated
pl atelet membranes demonstrates a pattern of
membrane glycoprote in s distinct from those of
other blood cells (Phillips and Agin 1977, Nurden
et al. 1981, George 1978). Of the approximate ly
50 polypept ides identified in isolated platelet
membranes (Sixma et al. 1982b) eight glycoprote in s (GP Ia, le, Ila, ls/lb, Id, Ilb, III, IV)
are externally or i ented and can be readily
labelled by non-penetrating radioactive probes
(Phillips 1980, Nurden et al. 1981, Peterson
1982). More recent l y an additiona l glycoprotein,
GP V, has been shown to be externa ll y oriented
(Berndt and Phillips 1981a). The external orientation of these gl ycoproteins contribut es to the
carbohydrate rich glycocalyx which gives the
pl atel et membrane its unique pr opert i es. Three
of these (GP lb, Ilb, and Illa) have been implicated in platelet adhesion-aggregation reactions
and will be discussed in further deta i l under
specific di sorders of platelet function.
The platelet unit membrane is a trilaminar
structure which demonstrates no differences from
other biologic membranes by transmission electron
microscopy (Fi gure 1). However, replicas of
freeze fractured platelets reveal diff erences in
the number and distribution
of intercalated particles on the exoplasmi c (E) and protoplasmic (P)
face of platelet membranes, a finding consistent
with the differences in transmembrane protein
composi t i on of these two membrane leaflets (White
and Conard 1973). The plate l et membrane contains
various enzyme systems including Na+K+and
ca++Mg++ATPases (Chambers et al. 1967, White
and Gerrard 1980) and adenylate cyclase (Haslam
1973, Mill s and Macfarl ane 1976).
The phospholipid or i entation in the plate l et
membrane i s asymmetrical (Schick et al. 1976) .
Durin g platelet stimulation reorientation of
membrane lipid s may provi de exposure of those
phospholipids which confer platelet coagulant
(PF 3) activity (Fanti and Ward 1955).
The submembranous zone is defined as that
membrane associated area which lies just internal
to the plasma membrane but peripheral to the
microtubular coil (Whit e 1982). Its composit i on
i s not well defined but the area is thought to
contain a regular system of filamentous elements
(White 1969), best visualized in osmotically
shocked pl at elets (Zucker -Frank lin 1970). This
zone of dense filaments appears to exclude

Functional Anatomy
Interpretation
of the three-dimensional data
provided by SEMrequires an understanding of
platelet ultrastructure
and function.
White has
introduced the concept of structural physiology
to emphasiz e the close correlation of morphologic
changes with physiologic and biochemical events
in st imulat ed platelets
(~/hit e 1971a). He has
proposed subdivision of platelet anatomy into
four functionally di stinct zones: 1) the
peripheral zone, 2) the sol -gel zone, 3) the
orga nell e zone and 4) the membrane systems (White
1982).
The peripheral zone:
The peripheral zone is responsible for the
plate l et's ability to recognize and respond to a
variety of stimu li.
It bears the receptor sites
for platelet agonists and inhibitors (Berndt and
Phillips 1981b), and it s unique composition is
responsible for th e platelet's
ability to adhere
to other platelets and to foreign surfaces
(Berndt and Philli ps 1981b, Nurden et al. 1981,
Phil lip s 1980, Phillips et al. 1980, Nurden and
Caen 1978). In addition, pl ate l et support for
pl asma cl otting is supplied by t hi s zone which
provides surface phospholip i ds (plate l et factor 3
or PF 3) that cata l yze several steps i n coagulation (Fanti and Ward 1955, Walsh 1978).
The peripheral zone is composed of three
morphologic domains: ( 1) the exter i or coat or
glycocalyx, (2) the unit membrane and (3) the
submembranous zone. The peripheral zone extends
into and line s the tortuous channel s of t he
s urfa ce-co nnected open canalicular system (OCS)
(Behnke 1967, 1970b) (Figure 1). This system of
surface-co nnected channels gives the platelet a
marked increase in surface area which
Morgenstern and Stark (1975) suggest, based on
morphometric anal ys i s of the OCSi n resting and
st imulated platelets,
may suppl y the membrane
requ ire d for pseudopodia fonnation following
platelet stimu l at i on. Milton and Frojmovic
(1979) came to simi lar concl~sions from measurements of surface area differences in resting and
stimu lated platelets from nonnal and Bernard
Soulier donors. In contras t, White and Clawson
(1980) have demonstrated by freeze fracture and
electron cytochemistry that channels of the OCS
are seldom single channels, but rather are an
anastamosing labyr inth of fenestrated channel s
that could not be easily evaginated.
These
authors conclude that the OCScould not provide
membrane for pseudopod f onnatio n. Egress of
granule contents through the OCShas been
demonstrated (White 1973) and engulfment of particulates occurs via thi s system (Movat et al.
1965, White 1972a, Barnhart and Noonan 1978,
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organelles from the submembrane region. The participation of the submembranous cytoskeleton in
the formation of membrane-cytoskeleton lin kages
seems likely.
Debus et al. (1981) have
demonstrated concentration of two actin modulating proteins, actin binding protein and alphaactinin in this region as well as within
pseudopods. Phillips et al.
(1980) have
isolated tritonized cytoskeletons from thrombin
stimulated aggregates and by SOSgel electrophoresis have demonstrated the presence of 2
membrane glycoproteins (GP IIb-IIIa) associated
with cytoskeletons enriched in actin, actin
binding protein, myosin, a 90K Dalton and a 56K
Dalton protein.
As compared to cytoskel etons
from non-aggregated thrombin-stimulated platelets
in which membrane components were no longer
present, there was a significantly
greater amount
of actin binding protein present when membrane
glycoproteins were linked to cytoskeletons.
In
addition the 90K and 56K components were not
identified in nonaggregated platelets.
Schollmeyer et al. (1978) demonstrated in vitro
that platelet actin binding protein promotes
actin filament crosslinking and that alphaact i ni n wil 1 produce lateral association of
cross-linked actin filaments into parallel
bundles. The presence of accessory proteins
which promote the association of actin into
parallel filament bundles suggests that this submembranous region may be involved in pseudopod
formation (White 1982).

molar ratio of 100 to 1 (Pollard 1975). This
suggests that actin has a role in platelet structure independent of its role in force generation
via actomyosin. Lind and Stossel (1982) review
the evidence that pseudopod formation is
controlled by rapid act in polymerization but is
not dependent on myosin . In addition, the presence i n platelets of a microtrabecular filament
network similar to that described in other cel l s
(Buckley and Porter 1975, Wolosewick and Porter
1979, Buckle y and Raju 1976) has been suggested
by stereo whole mount electron microscopy (Lewis
et al. 1980) and by transmission electron
microscopy (TEM)of detergent treated whole
mounts of adherent spread platelets (Mattson and
Zuiches 1981b). Several recent reviews on the
role of the platelet cytoskeleton in platelet
physiology are highly recommended (Adelstein and
Pollard 1978, Cohen et al. 1979, Gerrard et al.
1981, Lind and Stossel 1982, Fox and Phillips
1983, Nachmias 1983).
Organelle zone:
Organelles within this zone include
mitochondria, glycogen particles,
peroxisomes,
dense-core granules, alpha granules, and lysosomes (Figure 1). In response to a number of stimuli platelets secrete the contents of their
dense-core granules and al pha-granules.
This
secretory response is known as the "rel ease
reaction" (Grette 1962). Strong stimu li such as
thrombin and high concentrations of collagen may
also induce secretion of acid hydrolases from
lysosomes (Kaplan 1981). The granules play an
important role in the functional capacity of the
platelet.
The dense-core granules contain nonmetabolic adenine nucleotides (ADPand ATP),
calcium and serotonin.
Release of ADPpromotes
second wave aggregation in vitro.
Inhibition of
granule release by aspirin and other nonsteroidal
anti-inflammatory drugs is accompanied by a
measurable loss of second wave aggregation in
vitro and a variable prolongation of the bleeding
time.
Alpha granules contain platelet factor 4
(PF4), beta thromboglobulin (BTG), platelet
fibrinogen, van Willebrand factor (factor
VIII:VWF), fibronectin,
and platelet der{ved
growth factor.
The contents of platelet granules
are released by means of exocytosis (Holmsen
1965) into the surface connected canalicular
system (White 1973).
Further information on platelet granule
biochemistry, cel l biology, morphology and pathol ogy is provided by several recent reviews
(Kaplan 1981, Holmsen 1980).

Sol - Gel Zone:
Previously referred to as the hyaloplasm, the
sol - gel zone i s the viscous cell matrix which
contains proteins capable of being assembled into
various filament systems that ~ake up the platelet cytoskeleton.
This complex system of microfilaments, microtubules, and accessory/regulatory
proteins controls cell shape and provides the
motile forces for internal contraction and
granule secretion.
Platelet microtubules are
inv olved in maintenance of the discoid shape of
the resting platelet (White 1968a, White and
Krivit 1967). In sectioned platelets they
measure 25 nm in cross-sectional
diameter (White
1971a) forming a circumferential
bundle of 8-20
microtubules lying just under the platelet
membrane (Behnke 1970c) (Figure 1). Nachmias et
al. (1980) have presented evidence that the
peripheral bundle is composed of a single coiled
microtubule.
An impressive group of proteins associated
with the cytoskeleton have thus far been identified biochemically in platelets.
These include
actin (Probst and Luscher 1972), myosin (Booyse
et al. 1971, Adelstein et al. 1971, Pollard et
al.
1974), tropomyosin (Cohen and Cohen 1972),
tubulin (Crawford and Castle 1976) actin binding
protein (Lucas et al. 1976, Rosenberg et al.
1981), alpha-act inin (Rosenberg and Stracher
1981, Puszkin et al. 1978), vinculin (Billet et
al.
1981) and P235 (Colli er and Wang1982) as
well as several regulators of actin polymerization (Harris and Gooch 1981, Markey et al. 1981,
Wang and Bryan 1981, Lind et al. 1982). The
platelet contains actin in excess of myosin in a

The membrane systems:
Channel s of the surface-connected open canalicular system (OCS) and the dense tubular system
(DTS) make up the major part of this compartment.
These two membrane systems are often found in
intimate association with one anot her
(Breton-Gorius and Gui chard 1972, White 1972b).
The DTS, distinguished by it s content of
amorphous materia l (Behnke 197Gb), is the site of
calcium sequestration in the platelet (Gerrard et
al. 1978); it has been likened to the sarco-
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major role in revealing the precise fonn of tile
unactivated platelet and has also contributed to
our understanding of the complex process of
"shape change" that accompanies platelet activation (i.e. aggregation and adhesion reactions).

tubules of muscle (White 1975) while the OCShas
been compared to the transverse tubules of
muscle. ca++;Mg++ATPase activity is localized
in the membranes of the DTS (Cutler et al. 1978)
and calcium sequestration by the DTS is promoted
by rises in platelet
cyclic AMP. Many platelet
inhibitors act by stimulating platelet adenylate
cyclase to cause a rise in cyclic AMP(Haslam
1973, Haslam et al. 1977). There is evidence
that the DTSwith its peroxidase activity is the
site of prostaglandin synthesis (White 1972b,
Gerrard and White 1978, Breton-Gorius and
Guichard 1972). Platelet stimulation results in
release of arachidonic acid from phospholipids in
the platelet membrane. Arachidonic acid in turn
is metabolized to yield thromboxane A2 (TxA2), a
potent vasoconstrictor
and aggregator of platelets (Hamberg et al. 1975). Tv10 important
enzymes in TxA2 synthesis are cyclooxygenase and
thromboxane synthetase.
Production of TxA2 can
be blocked by acetylation of cyclooxygenase by
aspirin.
Inhibition of TxA2 synthesis results in
inhibition of ADPrelease and second wave aggregation.
Prostaglandin synthesis in endothelial
cells results in production of prostacyclin
(PGI2 ), a powerful disaggregator and inhibitor of
platelet aggregate fonnation as well as a vasod i la tor (Moncada et al . 1976). Alternate pathways
for platelet activation may involve release of
lysophosphatidic acid from membrane phosphotidylinositol as this component is an effective
platelet aggregator (Beauton et al. 1982).
It is clear that an intact endothelial
surface, with its antiaggregatory PGI2 activity,
is a powerful deterrent to inappropriate thranbus
fonnation.
Loss of endothelial cells results in
localized loss of this inhibitory activity and
allows accumulation of platelets.
The interaction of PGI2 and TxA2 as modulators of platelet function appears to be through
control of calcium flow from the DTS. Evidence
supports PGI2 action via a rise in cyclic AMP
which in turn activates a protein kinase that
phosphorylates a protein regulator of calcium
uptake into the DTS (Gerrard et al. 1978).
Active prostaglandins (PGG2, PGH2, TxA2) do not
measurably lower cyclic AMP,thus their action
may be directly on calcium release, acting as
ionophores.
For a detailed discussion of the
evidence in support of such a mechanism, the
reader is referred to the review by Gerrard and
White (1978). Additional reviews of the role of
prostaglandins in platelet function are provided
by Nalbandian and Henry (1978) and Cohen (1980).
Platelet

The resting platelet (Figure lA-C):
Preservation of platelets in their unstimulated, circulating state is best achieved by
drawing whole blood directly into aldehyde fixative (Hovig 1970a, Barnhart and Riddle 1967,
Barnhart et al. 1972, Hattori 1972). By this
technique the majority of platelets will appear
as biconvex discs with no, or only a few, small
pseudopods (Figure lA). Quantitation of the
number of pseudopods in directly fixed platelets
has been performed by several authors with good
agreement. Barnhart and associates have found
that 65-70% of directly fixed platelets are
smooth and free of pseudopods in both dogs
(Barnhart and Riddle 1967) and humans (Barnhart
et al. 1972). The remaining platelets showed
minor signs of activation; most of these remained
flat discs with 1 or 2 small thin projections.
By SEM, Hattori et al. (1969) found pseudopods to
emerge exclusively from the marginal portion of
the platelet at early stages of activation.
Bifurcation of pseudopods has been described
(Larrimer et al. 1970). Diameters of discoid
platelets range from 2-4 µm with an average
thickness of 0.4 to 0.8 µm (Hovig 1970a). Bigel
and associates (1967) found the average diameter
for normal adults to be 3.1 µm. The surface of
the unstimulated platelet appears rough in comparison to red cells, and occasional small protuberances and several pit-like openings can be
seen on the platelet surface (Figure lA). While
as many as 30 or more surface openings may be
seen by freeze fracture or thin section TEM
(Werner and Morgenstern 1980), they are often
difficult
to visualize by SEMpresumably due to
their small size.
By comparing SEMwith TEMof
the resting platelet, these surface pits
correspond to openings of the surface-connected
open canalicular system (Figure 18).
Werner
and Morgenstern (1980) found surface openings
more concentrated near the periphery of the
discoid platelet,
but we have not seen this
preferential
distribution.
TEMof the resting platelet demonstrates random dispersion of organelles such as granules,
mitochondria and glycogen particles.
Microfilaments are not discernible by ordinary
TEMtechniques.
Microtubules, on the other hand,
are readily seen in sectioned platelets as a
marginal band consisting of 8-20 individual
microtubules (Behnke 1970a, 1970c, \.Jhite 1971a,
Zucker-Franklin 1969) (Figures 18,C). Nachmias
et al. (1977, 1980) have been able, after
detergent extraction, to follow the peripheral
microtubule for several turns and conclude that
the microtubule bundle is composed of a single
long microtubule arranged in a coil.
Free ends
never exceeded two, lending more evidence to
Behnke's (1970c) earlier suggestion that the
peripheral microtubu l e bundle is composed of a
single long coiled microtubule.
This coil of microtubules maintains the

Shape

Platelets are exquisitely sensitive cells
which respond to minor mechanical and chemical
stimuli by alterations
in fonn and functional
state.
This sensitivity
makes it very difficult
to be certain that platelets under study are in
fact "resting" and not altered by some stimulus.
For this reason the search for appropriate anticoagulants and separation procedures, which preserve the platelet in a fonn that closely
approximates its native state, has been extensive.
Scanning electron microscopy has played a
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discoid shape of the resting platelet.
Evidence
for this was obtained from experiments which
showed that agents causing depolymerization of
microtubules, i.e., cold (White and Krivit 1967,
Zucker and Borelli 1954, Hovig 1970b) and colchicine, vincristine
and vinblastin (White 1968a,
Hovig 1970b) result in disc to sphere transformation of platelets.

mation are the major findings by TEM(White
1968a). However colchicine induces changes in
the DTS and produces inclusions which are not
described with cold (White 1968b).
While EDTAmay be the preferred anticoagulant
for certain preparative techniques, it should be
kept in mind that it is a poor choice for preservation of resting morphology. Platelets exposed
to EDTAat 37°C lose their disc shape and become
irregularly
swollen with multiple pseudopods by
phase contrast microscopy (Zucker and Borelli
1954) (Figure 3A,B). Externally they appear
similar to platelets sphered by exposure to cold,
treated with colchicine or stimulated by ADPand
thrombin. TEMstudies (White 1968c), however,
have demonstrated internal changes that are quite
distinct from those present following stimulation
with aggregating agents. The most prominent
change is dilatation of the OCS. In contrast to
cold and colchicine treatment, microtubules
remain intact in their usual submembranous position.
Furthermore, granules do not migrate
centrally as they do following ADPor thrombin
stimulation.
In White's study (1968c) these
alterations
were present as early as 13 min after
exposure to EDTA. Prolonged incubation in EDTA
(greater than 3-4 hours) leads to granule dissolution and swelling with an apparent increase in
mean platelet volume by Coulter counter electronic measurement (Mundschenk et al. 1976).
If experimental procedures require separation
of platelets from plasma, the maintenance of normal morphology and function is more difficult.
In general, platelets separated from plasma by a
variety of techniques including differential
centrifugation
(Mustard et al. 1972), gel filtration (Tangen et al. 1973) and albumin density
gradient centrifugation
(Walsh 1972) show comparable functional capacities if care is taken to
avoid low temperature, excessive mechanical stimulation, the introduction or relea se of agonist s
such as ADP, and depletion of plasma proteins
required for function (Mason et al. 1974).
Functional differences are slight as measured by
aggregability,
adhesion to glass, and content and
release of adenine nucleotides (Mason et al.
1974). In contrast, morphology is not equally
preserved by these techniques (Zucker et al.
1974).
Differential
centrifugation by the Mustard
technique (Mustard et al. 1972) at 37°C using /\.CD
anticoagulant produced the best preserved resting
morphology as studied by TEM. The important
features of this technique are the use of 37°C
rather than room temperature, the presence of
apyrase to inhibit any nucleotide released during
preparation, and the phosphate carbonate buffer
which supports preservation of platelet shape and
function.
In this same study gel filtration
at
room temperature produced moderate irregularities
in morphology with a few pseudopods. However
platelets
in general remained discoid and
organelles remained dispersed.
Gel filtration
is
preferred to centrifugation
by some investigators
(Akkerman et al. 1978). Platelets separated by
gel filtration
at 37°C are less activated than
those separated at room temperature (Nachmias
1980). Of the three separation techniques, albumin density gradient centrifugation
showed the

Effects of preparative procedures Q!!_ platelet
structure and function:
Most studies of platelet function require
collection of platelets in a solution appropriate
for experimentation.
Thus anticoagulated suspensions of platelets in native plasma or an
appropriate buffer are necessary.
Clearly the
mechanical stress associated with sample collection and centrifugation
as well as the effects of
various anticoagulants and salts can all
influence the structure and function of the final
product.
The size of the needle used for venipuncture
has been shown to have an effect on platelet
structure.
Hattori et al. (1977) found that a 23
gauge needle produced 50% fewer disc-shaped (i.e.
unstimulated) platelets than blood drawn through
an 18 gauge needle.
The choice of anticoagulant is especially
important.
Platelets drawn into citrate prior to
fixation will most closely resemble directlyfixed platelets;
nevertheless they often show
variable numbers of atypical fonns including
spherical, elongated, and ellipsoid forms
(Hattori et al. 1969, Zucker and Borelli 1954)
(Figure 2A-C).
Larrimer et al. (1970)
demonstrated that ACO,modified ACDand heparin
anticoagulation
produce platelets
(in PRP) similar in morphology to those in citrate.
Zucker
and Borelli (1954) demonstrated that temperature
plays a major role in preservation of resting
morphology; platelets collected in citrate and
oxalate and maintained at 37°C were mainly
discoid (85%) even though two thirds of the
discoid platelets contained small pseudopods. At
25°C fewer platelets remained discoid.
Nachmias
(1980) and Hovig (1970a,b) have confinned the
beneficial effect of processing at 37°C.
Phase microscopy shows that platelets exposed
to cold (0-4°C) undergo shape changes converting
from disc to "spi ney sphere" (Zucker and Borelli
1954). By SEMthese spiney spheres have highly
irregular surfaces with numerous bud-like pseudopods (Hovig 1970a,b) and only infrequent thin
elongated pseudopods (Larrimer et al. 1970).
Sphering is the result of cold-induced depolymerization of the marginal band of microtubules
(White and Krivit 1967). No evidence of internal
contraction, granule centralization
or central
migration of microtubules has been described by
TEM. Rewanning to 37°C results in recovery of
the discoid shape in about 30%of platelets,
associated with refonnation of the microtubule
bundle (White and Krivit 1967).
Colchicine, which also depolymerizes microtubules, causes platelet sphering (White 1968a,
Behnke 1970a) in vitro as well as in vivo (Hovig
197Gb). As with cold treatment depolymerization
of microtubules and sphering with pseudopod for-
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Use of SEMto St udy Platelets
Figure 1 A-C. Ultrastructure
of human discoid
unstimulated plat elets fixed immec!Tafel
y by
drawing blood dir ect l y into glutaraldehyde:- A:
SEM. Ba nd C: TEM. The discoid shape of the
unstimulated platelet i s best appreciated by SEM
in A. Openin gs of t he sur fa ce connected open canalicular system (OCS) are barely perceptible as
minute pit-lik e depress i ons on the sur fa ce
(arrows).
Position of underlying granul es i s not
discernib l e on the platelet surface. In the
transm i ssion el ectro n micrograph B, di sco i d unstimul ated plate l ets show randomly dispersed organelles in clu din g dense core granules (D),
al pha- granu l es(A), mi toc hondria (M), and masses of
glycogen particles (G) as well as channel s of OCS
(*). Dense core gra nules are distinguished from
alpha - granules by their bull's eye appearance.
The peripheral band of mi crotubules (MT) i s seen
in cross section in micrographs Band Cat the
poles of the di sco i d pl ate l ets.
The trilaminar
structure of the plasma membrane i s evident in C
(arrowhead). A and B: Bars = 1 mi crometer; C: Bar
= 0.1 micrometer.
Figure 2 A-C. Ultrastructure
of platel ets fixed
after~
p)eparat i on of citrated pl atele t- rich
pl asma PRP. A: SEM. Band C: TEM. In th e
sca nning micrograph A, note t he mild act i vat i on
that occurs dur in g the prepara ti on of PRP. Short
blu nt (arrowheads) and el ongated thin (arrows)
pseudopods are numerous. Most plate l ets remain
discoid but occas i onal plate l ets are sphered. A
red eel l (RBC) is present in the preparation.
Transmission electron mi crographs of pl ate l ets
fixed in PRP, Band C, show t he preservation of
the discoid shape as well as random di sperson of
organe ll es, and absence of a contracti l e wave.
The main manifestation of early, mil d st imulat i on
is pseudopod formation (arrows).
Hi gher magnif i cation in C demonstrates preservation of the
peripheral bundle of microtubules (MT). Thin
pseudopods appear to pre f erentia ll y fonn from the
margin of discoid plate l ets (arrows).
Bars = 1
micrometer.
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Fi gure 3 A-B. Ultrastructure
of platelets
coll ected ..i!:1_
EDTAanticoagulant.
A: SEM. B: TEM
.
Note loss of disco i d shape. Sphered platelets
s how infr equent pseudopods (white arrow). Openings
of the OCSare visible as pits on the surface
(bl ack arrows). Transmission el ectron micrograph
of EDTA
- anticoagu l ated platelets in B shows
absence of microtubules, marked dilatation of OCS
(*), and paucity of dense core and alpha - granu l es.
Bars= 1 micrometer.

least preserva tio n of morphology (Zucker et al.
1974). Improvements in albumin density gradient
separat i on techniques which include addition of
apyrase to the separa tion buffer are reported to
have improved the preservation of ultrastructure
v1ith this procedure (Wals h et al. 1977). Among
the newer separat ion techn iqu es, Stract an
gradients have been reported to preserve platelet
structure while metrizamide produces structural
a lt erations (Corash et al. 1977). Choice of
buffer wi11 al so influence the final product.
Tris buffers produce morphologic (Zucker et al.
1974) as well as functional abnonnalities (Lages
et al. 1975) while imidazole and triethanolamine
buffer s produce functional defects (Davis and
Phillip s 1971). Frojmovic and Milton (1982)
further recommend that an atmosphere of 5-6%
CO2 and a pH of 7.4 ±_0.1 are optimal.
Glutaraldehyde in a wide range of concentrations
(0.1 - 7.1%) is an effective fixative
for both scanning and transmission electron
microscopy of platelets
(Barnhart and Riddle
1967, Larrimer et al. 1970, Hovig 1970a,b,
Barnhart et al . 1972, Hattori 1972, Mattson et

al. 1977). Large volumes of fixative-buffer
so lution containing relatively low concentrat i ons
of glutaraldehyde are recommendedwhen platelets
are to be fixed in whole blood or plasma in order
to avoid coagulation of plasma protein s (Bess i s
and Weed 1972, White 1968d, Mattson et al. 1977).
Buffer concentration appears to be more critical
than glutaraldehyde concentration in preservation
of ultrastructure
as buffer is more freely diffusible than glutaraldehyde into the cell and
therefore produces a greater osmotic effect
(Arborgh et al. 1976, Barnhart and Riddle 1967).
We have found that initial preservation in 0.1%
glutaraldehyde in O.lM cacodylate buffer pH 7.4
gives excellent preservation for both SEMand TEM
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(Mattson et al. 1977). vJhile many early studies
of platelet three-dimensional structure yielded
useful information from air dried preparations,
for optimal preservation of orientation of
pseudopods and avoidance of collapse of cells,
critical
point drying (Polliack et al. 1973) or
lyophilization
(MJ Murphy 1972) is preferred.

platelet shape change the reader is referred
the review by \~hite (1974b).

to

ADPand thrombin (Figure 4A-G):
While platelets respond to many diverse stimuli, including mechanical shear forces, chemical agonists and inhibitors,
and particulates
such as latex, bacteria and collagen fibrils,
the
process of cell activation has been best worked
out for ADPand thrombin stimulation.
vJithin seconds following activation by ADP
(or thrombin), platelets transform from discs to
spheres and numerous short bulbous and a few
longer thin surface projections appear (White
1974b, 1968d, 1971b, Barnhart et al. 1972, Walsh
and Barnhart 1973, Barnhart 1978, Larrimer et al.
1970, Shoop et al. 1970, Hovig 1970a,b, Hattori
et al. 1969) (Figure 4A). Hattori (1972)
suggests from observation of samples taken 5
seconds after ADPaddition that bulbous, blunt
projections arising from the flat face of the
discoid platelet precede sphering. We have made
similar observations (Mattson and Craft,
unpublished observations) White (1974b) has
observed that the earliest change is formation of
short pseudopods most frequently at or near the
edge of the disc. This type of pseudopod with
its actin filament core is likely related to the
activation-induced
rapid polymerization of actin
reported by many investigators,
while the blunt
knobby surface undulations seen in early stimu l ation may be related to the internal reorganization that accompanies internal contraction.
We
have never observed parallel bundles of actin
filaments in these knobby, irregular surface convolutions
(Figure 4B). vJhile sphered platelets
are often referred to as swollen, there is not
general agreement that true volume increases
accompany shape change. The mean platelet volume
(MPV)of discoid platelets is approximatel y 4-8
µm3 (Frojmovic and Milton 1982), while the
reported MPVof EDTAsphered platelets varies
from 7.7-10.3 µm3 (Mundschenk et al. 1976).
Variation in the reported volumes for sphered
platelets appears to be due in part to differences in methodol ogy and anticoagulant.
In addition Bessman et al. (1982) have demonstrated that
there is a nonlinear inverse relationship between
MPVand platelet count which needs to be taken
into account in interpretation
of volume data.
Investigators using Coulter counter measurements
of mean platelet volume report increases in platelet volume (Bull and Zucker 1965, Laufer et al.
1979) while those estimating volume by microhematocrit (Born 1970) and microscopic measurements
(Milton and Frojmovic, 1977, 1979) find no change
in volume following agonist-induced shape change.
For an in-depth discussion of surface area and
volume change in st imulated platelets,
the reader
is referred to the recent review by Frojmovic and
Milton (1982).
Following ADPinduced shape change, loose
aggregates initially
fonn (Hovig 1970a, Barnhart
et al. 1972) in which individual platelets retain
their discrete identity (Figure 4C,D). Given a
sufficient stimulus, these ultimately become
tightly organized aggregates of fus ed platelets
(Figure 4E,F). By SEMthese irreversible
aggregates resemble coral with numerous fingers and
ridges fanned by the fused platelet masses

Shape Change
Morphologic changes have been observed in
platelets both in response to stimuli which
initiate aggregate formation and as part of the
platelet response during adhesion to surfaces.
vJhile these morphologic changes closely parallel
the biochemical and functional alterations
which
occur during aggregation, granule release, and
adhesion, they appear to be separable events.
The search for the role of shape change in these
functional reactions has led to a variety of
structural-functional
studies employing numerous
agonists and inhibitors.
vJhile these studies
have clearly indicated that certain morphologic
events can be correlated to structural rearrang e ments within the platelet,
the role of shape
change in augmenting platelet function has yet to
be fully elucidated.
Morphologic alterations
that accompany
aggregation:
The platelet's
response to stimu li is dependent on the nature, strength, and duration of the
stimulus as well as the responsiveness of the
platelet itself.
vJith suboptimal stimuli, activation will be transient and reversible but with
stronger stimuli, irreversible
activation will
occur (Zucker and Peterson 1970, Larrimer et al.
1970, Barnhart et al. 1972).
The addition of most platelet stimulators to
platelets in suspension results in dramatic
morphologic changes commonly referred to as
platelet "shape change". Documentation of shape
change may be based on direct microscopic observation or on indirect measurement of light
transmission by aggregometry (Born 1970). vJith
aggregometry, disc to sphere transformation is
observed in a stirred suspension of platelets as
a decrease in light transmission as well as a
decrease in the amplitude of the recorder pen
oscillations
(Latimer et al. 1977, O'Brien 1970).
The change in amplitude is due to lightdeflecting differences between discs and spheres.
Because discoid platelets are asymmetrical, they
are oriented by the shearing forces of the stir
bar to produce a visible swirl which is recorded
as rapid oscillations.
Immediately after addition of an aggregating agent, discoid platelets
transform into spheres which no longer show the
swirl effect and the oscillations
disappear.
By SEM,the two major features of agonistinduced shape change are sphering and extension
of surface projections (vJhite 1974b). These surface projections are variably referred to as
microspikes, filopodia (Nachmias et al. 1979) or
pseudopods (Hovig 1970a,b, Barnhart et al. 1972).
Surface projections may be short, blunt and
generally rounded, or thin, elongated and
cyl ind ri cal • Whenthere is a preponderance of
elongated, thin pseudopods, platelets are often
referred to as "dendritic" in fonn (Bessis 1973,
Hovig 1970b). For an excellent discussion of
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which fonn following stimulation are present in
bundles in pseudopods and within the platelet
body (Nachmias 1980, Jennings et al. 1981,
Gonella and Nachmias 1981). While actin bundles
produced by stimulation are sensitive to depolymerization by cytochalasins, filamentous actin
present in unstimulated platelets is not (Fox and
Phillips 1981).
Agonist-induced cytoskeletal changes are
associated with simultaneous membrane changes.
Association of membrane GP !lb-Illa
complex
with the underlying cytoskeleton occurs following
thrombin (Phillips et al. 1980) and conconavalin
A (Painter and Ginsberg 1982) aggregation but has
not been observed following ADPaggregation
(Rol:man et al. 1982). These reported differences
are surprising since ADPand thrombin produce
almost indistinguishable
morphologic changes
(White 1968d) and both require fibrinogen binding
to GP !lb-Illa complex for aggregation to occur.
Epinephrine and other biologic amines (Figure
5A-C):
The question of whether shape change is
required for either aggregation or granule
release is raised by studies on epinephrine
induced aggregation.
This agonist produces a
two-wave aggregation response similar to that
seen with ADP. The primary wave is induced by
the epinephrine while the second wave is mediated
by thromboxane A2 production and ADPrelease from
dense-core granules.
The primary wave of epinephrine aggregation, unlike ADPor thrombin stimulation, produces no shape change, no granule
centralization
and no contractile wave as evidenced by centralized filaments (Figure 5A-C).
Nevertheless granule release can occur. A more
recent role for epinephrine in platelet reactions
has been postulated by Rao et al. (1980, 1981).
These authors suggest that alpha-adrenergic
receptor occupancy directly alters the platelet
membrane, allowing irreversible
aggregation to
occur in response to a second agonist even in the
absence of prostaglandin synthesis or release of
granule constituents.
The effect of biologic amines on platelets is
not unifonn. Epinephrine, norepinephrine and
serotonin induce aggregation and enhance
spreading on a formvar surface (Barnha~t et al.
1972). Serotonin, in contrast to epinephrine,
produces platelet sphering with marked surface
convolutions as seen by SEM. Another vasoactive
amine, histamine, acts as a platelet inhibitor
which diminishes contact-activated
shape change
(Barnhart et al. 1972).

(Figure 4E).
With low concentrations of ADP
irreversible
aggregates do not fonn and disaggregation occurs; this is associated with restoration of the discoid fonn.
Changes in surface contour are associated
with internal transfonnations.
The randomly
dispersed organelles of the resting platelet
migrate centrally to fonn a nucleoid of granules
and contractile
filaments (Figure 4B). Gerrard
et al. (1979) have demonstrated that the contractile wave is oriented toward the aggregate center
and thus the centralized organelles and contractile apparatus will be displaced in this direction.
This reorganization is associated with
central migration of the peripheral microtubular
bundle (White 1979) resulting in loss of the
discoid shape and sphering.
Central displacement
of microtubules is apparently accomplished by
depolymerization of tubulin with repolymerization
at the new location.
A transient decrease in
polymerized tubulin content of platelets has been
demonstrated immediately following stimulation by
thrombin, ADP, epinephrine, or collagen with
recovery of baseline polymerization by 1-4 min
(Steiner and Ikeda 1979). While thrombin and ADP
induced internal reorganization are identical,
central fusion of granules has been reported with
thrombin stimulation but not with ADPstimulation
(White 1968b).
The state of microfilament polymerization in
the resting and activated cell has also been an
area of considerable interest since both cell
shape and internal reorganization require participation of cytoskeletal components. In aggregation centralization
of granules and microtubule
coils is accompanied by a wave of contraction
that is visualized as the appearance of a dense
mass of poorly defined microfilaments in the cell
center (White 1974a,b) (Figure 4B).
Because ultrastructural
visualization
of
filament organization is exceedingly difficult,
most studies on the state of contractile
protein
polymerization have used biochemical assays.
Nachmias and her colleagues (1977, 1979), using
the local anesthetics lidocaine and tetracaine
which are inhibitors of microfilament polymerization, found that actin in the pseudopod-free,
resting platelet is mainly monomeric or nonpolymerized G-actin.
A rapid increase in polymerized actin (F-actin) following chilling,
thrombin and ADPstimulation has been
demonstrated (Phillips et al . 1980, Jennings and
Phillips 1981, Pribluda et al. 1981). Fox et al.
(1981) found 40% of total actin was F-actin in
resting platelets that were lysed under stabilizing conditions; this rose to 65% F-actin
following thrombin stimulation.
Others have
reported between 20 and 50% F-actin in unstimulated platelets using a DNase I inhibition assay
(Gitler et al. 1980, Carlsson et al. 1979,
Jennings et al. 1981, Pribluda et al. 1981),
even in the presence of tetracaine inhibition
(Davies and Palek, 1982). F-actin in the resting
platelet may represent a stable network of filaments responsible for the spatial relationships
of organelles.
This stable system of filaments
presumably includes the submembranous filaments
which are intimately associated with the microtubular coil on its internal side and the plasma
membrane on its external aspect.
Actin filaments

Coll agen:
Collagen is one of the strongest platelet
agonists.
Collagen induced shape change is similar in many respects to that seen with ADPand
thrombin (Larrimer et al. 1970). Disc to sphere
transformation is rapid and numerous long thin
psuedopods are produced (Figure 6). Barnhart and
Noonan (1978) demonstrated that as many as 16-20
pseudopods may be present per platelet.
Terminal
bulbous swellings have been described at the tips
of pseudopods by SEM(Polasek 1982). By TEM
these endings contain multivesicular structures
(Warren and Vales 1972a; b).
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Figure 4 A-G. Ultrastructure
of ADPaggregation . A
and B: Samples harvested at 5 seconds after addition of ADPand examined by SEM(A) and TEM(B).
C and D: Samples harvested at 1 minute and examined by SEM(C) and TEM(u). E and F: Samples
harvested at 3 minutes and examined by SEM(E) and
TEM(F). G: Typical 2 wave ADPaggregation curve
demonstrating points of sampling. The earliest (5
second) shape change induced by ADPis seen in A
and B. In A, SEMdemonstrates the disc to sphere
transformation.
While thin pseudopods are present
(arrow), the major surface alteration
is the presence of blunt, short convolutions which give the
platelets a cerebroid appearance. Openings of the
OCS are not present on the crests of these convolutions as seen by SEMin A, but appear to exit
from the bases of these projections as
demonstrated by TEMin B (arrows).
By TEM in B,
centralization
of organelles (0 ) is evident as is
concentration of densely staining cytoplasmic
matrix (M). This condensed matrix is presumably
composed of contractile elements. Note the ,surface convolutions are devoid of organelles and the
microtubule bundle is no longer present at the
platelet periphery.
C and D demonstrate a loose
reversible platelet aggregate from a sample
collected at the peak of primary wave aggregation
(1 minute).
By SEM(C), individual platelets are
ea s ily identified within the aggregate.
Entrapped
red cells (RBC) and a rare lymphocyte (L) are
seen. TEMin D demonstrates that the integrity of
individual platelets within the primary aggregate
is preserved.
In E and F the irreversible
aggregates harvested at the peak of second wave aggregation (3 minutes) show loss of individual
platelet integrity.
By SEM(E), the aggregates
resemble a coral reef with projection of wide
ridges composed of fused platelets.
The surface
has a rough cobblestone appearance and distinct
margins of platelets are not discerned.
Occasionally an intact platelet is recognizable on
the surface (arrow). By TEM(F), loss of platelet
contents and focal disruption of membranes are
seen (Circle).
Bars =l micrometer.
(Micrograph A
is reprinted with permission from Stain Technol
52: 151-158, 1977).
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Platelets activated in vivo:
Increased numbers of abnormal forms and
sphered platelets both with and without pseudopods have been identified by SEMin immediately
fixed blood from patients with disseminated
intravascular
thrombosis (DIC), idiopathic thrombocytopenia (ITP), preleukemia, acute promyelocytic leukemia, and pregnancy (Hattori et al. 1979)
as well as in spur cell anemia secondary to hepatocellular
disease (Doll 1982). SEMhas been
used to study the interaction of platelets with
blood borne tumor cells.
Some tumor cells are
able to activate platelets to change shape and
form aggregates in vitro and in vivo (Figure 7).
The presence of aggregates distant
from the
tumor suggests that soluble tumor products in the
media may be responsible for the aggregation of
platelets.
Platelet aggregation by tumor cells
in the circulation does not appear to be essential for tumor eel l metastasis in the spontaneous
metastasis animal model (Estrada, 1983). The
morphology of platelet tumor cell interaction has
been the subject of a recent review (Warren
1978).
Several basic substances including polylysine, protamine, and polyornithine are strong
platelet stimuli which induce shape change and
aggregation in vitro.
It is therefore of
interest that a biologic basic substance, myelin
basic protein (MBP), induces dramatic shape
changes although no release has been demonstrated
( Laubscher et al. 1979).
Contact activation of adherent platelets (Figure
8A-C):
Platelet adhesion is a complex process in
which at least 3 partially independent events,
cell attachment, morphologic changes (i.e.
spreading) and surface induced release, participate
(Baumgartner et al. 1976). The morphologic changes which accompany adhesion bear many
similarities
to those described in aggregating
platelets
in suspension. These changes can be
visualized by light microscopy as platelets react
to a glass surface and have been well studied by
dark field (Fonio and Schwendener 1942), phase
contrast (Bessis and Tabius 1955) and differential interference contrast (DIC) (Allen et al.
1979, Barnhart et al. 1972) microscopy. Bessis
and h1s coworkers characterized the successive
stages of platelet shape change, labeling the
evolving pl ate let forms round or di scoi da l ,
dendritic,
transitional
and spread (Bessis and
Bricka 1952, Bessis and Burnstein 1949, Bessis
and Tabius 1955). More recent studies by Allen
and coworkers (1979) combined DIC cinephotography of viable platelets with scanning
electron microscopy of fixed platelets to obtain
further detail on surface structural changes.
They observed early extension of both short nonmotile protuberances and longer cylindrical,
tapered pseudopods which extended and retracted
until surface contact was made. Platelet
cytoplasm (hyalomere) spread radially either symmetrically or asymmetrically.
Hyalomere
spreading could occur whether or not preceded by
pseudopodial activity.
Whenpreceded by pseudopods, the hyaloplasm spread as a web connecting
adjacent projections.
Granules were concentrated

J. C. Mattson

Figure 5 A-C. Ultrastructure
of epinephrine
induced primary wave aggregates.
A and B: SEM
and C: TEM. Samples of primary aggregates sho1~
that sphering does not accompany primary wave
aggregation induced by epinephrine.
By SEM(A)
aggregates appear composed of plump but discoid
platelets.
At higher magnification (B) these platelets show a few thin pseudopods but no surface
convolutions.
TEM(C) of these primary aggregates
shows little evidence of centralization
of organelles or condensation of cytoplasmic matrix typical of ADP aggregation.
Bars= 1 micrometer.

Figure 7. Platelet-tumor cell interaction.
Scanning electron micrograph demonstrates the in
vitro activation of platelets (P) by tumor cells
(T) derived from rat 12763 adenocarcinoma (clo ne
MTF7). Aggregation occurs both with platelets in
contact with tumor cells and with platelets
distant from tumor cells suggesting that a tumor
product in the media promotes aggregation.
(Reproduced with permission of J Estrada).

Figure 6. Scanning electron micrograph of collagen
induced aggregation.
Disc to sphere transformation is accompanied by extensive pseudopod formation (Arrows). Collagen fibrils (C) are present
in the background. Bar= 1 micrometer.
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centrally into a hillock reminiscent of the granule centralization
observed in platelet aggregates (White 1974a). As spreading proceeded, this
hillock flattened.
Using mepacrine labeling,
these authors were able to observe dense body
release.
They also observed that platelets
settling on top of spread platelets were blocked
from the substrate stimulus and did not spread,
although they did partially degranulate and
formed many pseudopods which interlocked as
aggregates formed.
The sequence of morphologic changes on formvar are similar to those observed with glass
activated platelets (Lewis et al. 1980, Barnhart
and Riddle 1967, Mattson 1981) (Figure 8A-C).
Using SEMstereomicroscopy of pigeon thrombocytes
adherent to formvar, Taylor and Lewis (1981)
extended Allen's observations and demonstrated
that attachment of pseudopodia and of the
spreading edge of the hyalomere is discontinuous.
Stereo whole mount TEMdemonstrated fine filament
strands connecting the uplifted membrane to the
formvar surface.
Several investigators
(Braunsteiner and Pakesch 1956, Rebuck and Riddle
1964, Riddle and Schatz 1970, Barnhart and Riddle
1967, Barnhart et al. 1970, 1972, and Barnhart
and Noonan 1978) have used formvar activation as
the basis for a functional assay of platelet
reactivity.
Platelets in whole blood, stimulated
by a timed exposure to formvar can be fixed as
whole mounts and examined by either TEMor SEM.
Activated forms, s imilar to those described by
Bessis (1973) and Allen et al. (1979) on glass,
include round, abortive-dendritic,
dendritic,
intermediate, and spread forms (Figure 8); these
can be quantitated to give an index of reactivity.
In addition, aggregrate formation can be
quantitated.
Hyperactivity, manifested as
increased spreading and greater aggregate formation, has been detected in patients with
myocardial infarction (MI) in the immediate post
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-

Figure 8 A-C. Ultrastructure of contact activated
platelets.
A and B: TEM
. C: SEM. Transmiss ion
electron micrographs A and B demonstrate whole
mount preparations of adherent and spread ing platelets on carbon-stabilized
formvar films.
Extraction-fixation
in 2.5% glutaraldehyde containing 1% NP40 allows visualization
of cytoskeleton in spread forms. Early forms are seen in A;
these include sphered (S), abort ive-dendritic
(AD), and dendritic (D) forms. In 8, later spread
forms are demonstrated. As spreading proceeds,
intermediate forms ( I) show cytoplasmic spreading
between pseudopods. Later forms include i ncompletel y (IS) and completely spread (CS) platelets.
Centralization
of organelles (circle) is clearly
evident in spreading platelets,
and rearrangement
of cytoskeletal filaments (F) can be seen.
Scanning electron micrograph C of adherent platelets demonstrates the 3-dimensional appearance of
contact activated platelets.
Adhesive substrate
is a ca rbon-formva r coated glass covers lip; contact time 60 minutes. Dendritic platelets (D)
show numerous thin pseudopods radiating from plump
sphered bodies. Spread platelets have centralized
granules which first appear as a central hillock
(H) and then flatten revealing the outline of
individual granules (G). Bars = 1 micrometer.
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1979). Further support for this is found in SEM
studies showing an increase in platelet adhes ion
to fibronectin-treated
fibrillar
collagen with
marked potentiation of spreading to fom, a pavement like covering of the substrate (Koteliansky
et al. 1981). The role of fibronect in in adhesion is far from clear, but from the data
available it may have a major role in supporting
platelet spreading with a more minor participation
in promotion of the attachment or contact phase of adhesion.
Platelets adherent to glass beads retrieved
from glass bead retention columns show the same
morphologic transfom,ation v1ith development of
dendritic and spread fom,s as described with
glass slides, fom,var, and collagen.
PGI2
inhibition of glass bead retention is due to
inhibition of aggregation.
Platelet attachment
appears to be intact but spreading is markedly
inhibited (Hattori et al. 1974a,b, Tsao and
Krajewski 1982). Inhibition of spreading has
been demonstrated by cold (Bessis 1973), cytochalasin B (Taylor and Lewis 1981) and PGI2 (Tsao
and Kraje\1ski 1982). In all instances \~hen these
agents or conditions were introduced after
spreading had occurred, retraction of spread
hyaloplasm left long fine pseudopods behind
attached to the substrate.
Cytoskeletal architecture in spreading platelets has been studied using fom,var as the activating substrate and partial detergent extraction
(Nachmias and Sullender 1978, Nachmias 1980,
Mattson and Zuiches 1981b, Mattson 1981), whole
mount electron microscopy (Lewis et al. 1980,
Taylor and Lewis 1981) and high voltage electron
microscopy (Albrecht and Lewis 1982) to visualize
the platelet cytoskeleton.
Cytoskeletal architecture in detergent extracted platelets is
demonstrated in Figure 8B.
Cytoskeletal organization in dendritic platelets shows radial extension of bundles of microfilaments into pseudopods, while in the fully
spread platelet there is reorientation of microfilament bundles into circumferential
loose
parallel arrays (Lewis et al. 1980, Mattson and
Zuiches 198la,b, Mattson 1981, Nachmias and
Sul lender 1978, Nachmias 1980). A microtrabecular lattice of shorter fine filaments is evident
throughout the platelet cytoplasm and there is a
condensed filament network in the submembranous
cortex (Lewis et al. 1980, Mattson and Zuiches
1981a, b). This reorganization of the platelet
cytoskeleton parallels platelet spreading and
granule release (Allen et al. 1979). Debus et
al. (1981) have identified by immunofluorescence
that the circumferential microfilaments are actin
and that myosin is concentrated both centrally
and at the margin of the spread platelet.
An
organization of circumferential actin filaments
and central concentration of myosin is consistent
with the hypothesis that actomyosin interactions
result in contraction of actin microfilaments to
provide force generation for granule release
(Gerrard et al. 1981). Similarly the continuity
of radial filaments in pseudopods with the more
central circumferential filaments would allow
central actomyosin contraction to play a role in
pseudopod retraction.
The microtubu le coil , important to maintenance

MI period (100%) as well as several months later
(67%) (Riddle and Schatz 1970). Similar
increases in reactivity to glass and collagen has
been described in ischemic heart disease by Aznar
et al. (1979). Hyper-reactivity to fonnvar has
also been seen in patients with arthritis
(Riddle
et al. 1981) as well as in patients with acute
stroke (88%) (Gilroy et al. 1969, Barnhart et al.
1970) but in only 36%of patients with chronic
cerebrovascular disease (Walsh et al. 1975).
Fibrinolytic products in low concentration
enhance platelet contact activation while in high
concentrations are inhibitory (Barnhart and
Riddle 1967).
This system has also been useful in evaluating platelet reaction to various chemical
stimuli.
Enhanced platelet activation by biologic amines (serotonin, epinephrine, and
norepinephrine), thrombin, collagen, adenine
nucleotides, fibrin split products and low concentrations of Hagemanfactor has been
demonstrated (Barnhart et al. 1970, 1972,
Barnhart and Riddle 1967, Walsh and Barnhart
1973). In addition these authors have studied
inhibition of membrane reactivity by low molecular weight dextran, ouabain, histamine, urea in
glucose, and sodium metabisulfite and acetylsalicylic acid (Barnhart et al. 1970, 1972) using SEM
as an adjunct to TEMand DIC light microscopy.
The adherence of platelets to biological
substrates initiates
events similar to those
described with glass and fom,var activation.
Scanning electron microscopy of human platelets
adherent to a collagen coated substrate shows a
similar sequence of morphologic changes (Elbert
et al. 1979). With conversion of discoid platelets to spheres accompanied by a progressive
increase over time in bulbous and fine elongated
pseudopods, platelet spreading and ultimate
aggregate fom,ation developed over a 16 minute
time course. These authors reported that
PGiz did not apparently inhibit adhesion
(st icking) to collagen but sphering and pseudopod
fom,ation were retarded and aggregates were fewer
and smaller. Aspirin (10 mg%)inhibited aggregation but not adhesion on the collagen substrate
and morphologic transfom,ation was abnom,al with
more pleomorphic fonns. Sulfinpyrazene (10 mg%)
proved least effective as an inhibitor producing
no substantial decrease in aggregate size
although morphologic alterations were similar to
those seen with aspirin.
A role for the adhesive protein fibronectin
in platelet-collagen
interactions has been postulated (Bensusan et al. 1978). Fibronectin is
present in platelet alpha-granules (Zucker et al.
1979, Plow et al. 1979) and is released upon stimulation by thrombin and high concentrations of
collagen (Zucker et al. 1979). Fibronectin can
be identified on the platelet surface following
secretion (Ginsberg et al. 1981) and on spread
platelets adherent to collagen fibers or plastic,
but not on unstimulated gel-filtered
platelets
(Lahav and Hynes 1981). Santoro and Cunningham
(1979) demonstrated only a slight reduction in
adhesion after treatment of washed platelets with
anti-fibronectin
antibody or Fab fragments. On
the other hand, platelet spreading on both collagen and fibrinogen substrates appears to be
potentiated by fibronectin (Grinnell et al.
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of the discoid shape of the unstimulated platelet, appears to reorganize in the contactactivated platelet but the precise sequence of
events is unclear.
Using immunofluorescence with
anti-tubulin
antibodies, Debus et al. (1981) have
observed brightly stained microtubular rings with
mean maximumdiameters of 3.4 µmin discoid platelets.
In dendritic platelets these coils
decreased in diameter to 2.1 + 0.44 µm with one
or two arms projecting out from the ring presumably into pseudopods. In cor.t rast Reeber et
al. (1983) have observed a gradual breakdown of
the microtubule ring during spreading on
poly-L-lysine coated surfaces.
In these studies
anti-tubulin
staining became diffuse within the
platelet body with bright staining of some
pseudopodia. One can see similar diffusely
stained dendritic platelets among the spread platelets in photomicrographs taken at 2 hrs by
Debus et al. (1981). Whether this diffuse
staining represents depolymerization of microtubules is not clear nor is it clear in comparing
the two studies whether this phase precedes or
follows the formation of a microtubular ring of
decreased diameter.
Immunofluorescence of more
fully spread platelets in 2 hr specimens (Debus
et al. 1981) showed various complex arrangements
of curving microtubules seen both close to the
central granul omere and in the distal spreading
cytoplasm suggesting that if depolymerization
occurs, reformation of microtubules takes place
in later stages of spreading.
Ult rast ructura l
studies support the concept of microtubule
reorganization during platelet spreading on surfaces (Lewis et al. 1980, 1982, Mattson and
Zuiches 198la,b).
Using whole mount stereo
electron microscopy of platelets from the African
green monkey, Lewis et al. (1982) observed that
during the early stages of adhesion, microtubules
assumed a radial orientation into the pseudopods
of dendritic platelets.
As hyalomere spreading
proceeded, microtubules paralleled the major axes
of the cells until in fully spread platelets
the microtubules were present in a diffuse circumferential pattern.
Replacement of the
coiled microtubule ring of resting platelets with
gently curving circumferential
microtubules in
the cytoplasm of the fully spread platelet has
also been observed in human platelets using
detergent treated whole mounts (Mattson and
Zuiches 198la,b).
There is evidence that these changes in
microtubule organization may not, be required for
platelet spreading to occur. Lewis et al. (1982)
have demonstrated that colchicineand vinblastin
treatment of platelets,
which dissociates microtubules, does not eliminate spreading although a
slight reduction in the percentage of fully
spread cells was observed. Similarly, prevention
of depolymerization of microtubules using the
microtubule stabilizing
agent, Taxol, does not
interfere with platelet shape change (White and
Sauk,1984). One might speculate from the available
data that microtubule reorganization occurs as a
secondary event during adhesion-associated
shape
change. A reasonable sequence of events might
be: (1) contact activation of the platelet with
centralization
of granules and a decrease in the
microtubule coil diameter resulting in platelet
sphering in a manner similar to the initial events

seen in aggregating platelets (White 1968d), (2)
simultaneous extension of the two ends of the
microtubul ar coil into pseudopods as the dendrit ic platelet develops, (3) a phase of microtubule
depolymerization in the dendritic platelet as
cytosol calcium levels rise and (4) reformation
of microtubules within the cytoplasm of the
spreading platelet as gently curving structures
oriented circumferentially
both around the
central granul omere and throughout the spreading
cytoplasm.
Disorders of Platelet

Function

This review will limit its discussion to
three congenital bleeding disorders chosen
because they represent specific defects in the
membrane related functions, aggregation and adhesion, and are therefore amenable to SEMstudy.
Indeed, three dimensional structural studies,
either SEMor whole mount TEMadhesion assays, of
these disorders have contributed significantly
more information relative to functional capacity
than has conventional TEMof sectioned platelets.
For an in-depth review of the literature
on
the historic,
physiologic, and biochemical
aspects of these disorders the reader is referred
to several excellent reviews (Lusher and Barnhart
1977, Bloom 1980, Weiss 1980, Barnhart and Lusher
1981, Zimmermanand Ruggeri 1982).
Von Willebrand's Disease (VWD):
In 1926 von Willebrand described 23 members
of a family with moderately severe clinical
bleeding, prolonged bleeding times and an autosomal pattern of inheritance.
Almost 30 yea rs
later it was established that an abnormality of
Factor VIII was present in this disorder when
Alexander and Goldstein (1953) and later Juergens
et al. (1957) reported a deficiency of Factor
VIII procoagulant activity.
As the biochemical
and functional characteristics
of the Factor VIII
molecule have been elucidated, it has become
apparent that patients with VWD
may express deficiencies in a variety of Factor VIII related
functions.
In 1971 Zimmermanet al. demonstrated
that severe VWD
patients were often deficient in
both Factor VIII procoagulant activity and Factor
vTTTrelated antigen (an antigen identified by a
rabbit antibody raised against human Factor VIII)
in contrast to hemophiliacs who lack procoagulant
activity but possess normal amounts of Factor
VIII related antigen.
With the discovery of the
ability of the antibiotic ristocetin to aggregate
platelets in platelet-rich
plasma from normal
individuals but not from von Willebrand's
patients, a biologic assay was developed for
quantitating the plasma activity missing in VWD
patients (Howard and Firkin 1971). This missing
plasma factor in VWD
is called von Willebrand
factor while ristocetin cofactor activity refers
to one functional attribute of von Willebrand
factor, i.e. that measured in the ristocetin
aggregation assay. In addition to support of
ristocetin
induced platelet aggregation, von
Willebrand factor is required for adhesion of
platelets to subendothelium (Tschopp et al.
1974), retention of platelets on glass bead
filters
(Salzman 1963, Hattori et al. 1974c), and
maintenance of a normal bleeding time in vivo.
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suggesting a defect in synthesis or degradation
within the cell of origin prior to release.
"Pseudo" von Willebrand's disease has been
recently described (Gralnick et al. 1981, Weiss
et al. 1982). In this disorder, which resembles
type IIB VWD,a platelet abnormality is responsible for enhanced von Willebrand factor-platelet
interaction following ristocetin stimulation.
The abnormal platelets bind normal von Willebrand
factor at lower concentrations of ristocetin than
required to initiate von Willebrand factor
binding to normal platelets.
In one instance,
von Willebrand factor induced platelet aggregation without ristocetin.
The absence of large
multimers in the plasma but not in the platelets
in this disorder is probably due to enhanced
removal by binding to platelets (Zimmermanand
Ruggeri 1982).
Conventional ultrastructural
studies on
ultrathin sections have not revealed any
diagnostic morphologic alterations
in VWDplatelets.
While several authors (Schulz et al. 1958 ,
Jean et al. 1963, Marx and Jean 1964, Boisseau et
al. 1976) have described abnormal drumstick granules in platelets of patients with von
Willebrand's disease, Hovig (1968) and Lusher and
Barnhart (1977), in their reviews of platelet
morphology in disease, point out that this
ultrastructural
finding has been observed in
other pathologic conditions (Jean et al. 1963,
Marx and Jean 1964, Seip and Kjaerheim 1965) and
in normal dog and human platelets (Hovig 1968).
Lusher and Barnhart (1977) suggest that morphometric analysis would provide quantitative data
on the frequency of these granules in VWDvs.
normal platelets.
Platelets from swine with VWD
show no abnormalities by SEMor TEM;in addition,
they are capable of normal uptake of latex particles (Lewis and Bowie 1978).
Scanning electron microscopy has yielded
important data on the responsiveness of VWDplatelets to foreign and biologic surfaces.
By SEM,
reduced membrane responsiveness to formvar in a
non-flow system has been observed in VWDplatelets (Lusher and Barnhart 1977, Barnhart 1978)
although adhesion itself was described as fair in
this test system. Altered surface responsiveness
was reflected in failure of disc to sphere transformation, defective pseudopod formation with a
decrease in fully developed dendritic platelets,
and increased numbers of abnorma1 spread forms
(Lusher and Barnhart 1977).
In a similar manner, defective adhesion of
VWDplatelets to subendothelium has been studied
ultrastructurally
by SEM. Using an umbilical
vein ex vivo perfusion model, Barnhart and her
associates (Lusher and Barnhart 1977, Barnhart
1978, Barnhart et al. 1981) demonstrated uniformly decreased adhesion of VWDplatelets
ranging from 7-51% of normal. While the majority
of the VWDpatients tested showed decreased
spreading of platelets in addition to decreased
adhesion, two patients demonstrated normal
spreading over the exposed subendothelium.
Bolhuis et al. (1981) reported that binding of
von Willebrand factor to subendothelium precedes
platelet adhesion and spreading.
Sixma et al.
(1982a), using human artery subendothelium in an
annular perfusion chamber, have demonstrated a
greater degree of impaired spreading in type !IA,

Defective adhesion to subendothelium has been
demonstrated on rabbit aorta (Tschopp et al •
1974), human umbi1ical vein (Lusher and Barnhart
1977, Barnhart 1978, Barnhart et al. 1981), and
human renal artery (Sakariassen et al. 1979).
The defect in adhesion to rabbit aortic subendothelium in VWD
as demonstrated in an annular
perfusion chamber is shear rate dependent (Weiss
et al. 1978). The requirement for von Wi11ebrand
factor in normal adhesion of platelets in unanticoagulated blood to subendothelium is greatest
at shear rates of 2600-3300 sec-1, within the
range of those shear rates found in the microvasculature (Weiss et al. 1978, Baumgartner et
al. 1977). Baumgartner et al. (1980) have reproduced the adhesion defect of von Willebrand
disease using antibodies to human factor VIII/van
Willebrand factor.
In their recent review, Zimmermanand Ruggeri
(1982) summarize the evidence that Factor VIII is
a molecular complex between the small procoagulant molecule and the high molecular weight polymeric von Willebrand factor molecule, and that
the von Willehrand factor activity of the Factor
VIII complex is dependent on the presence of high
molecular weight multimers (Ruggeri and Zimmerman
1980, 1981).
Classification
of subtypes of VWDis based on
differentiation
of abnormalities of von
Willebrand factor in plasma and platelets as well
as on identification
of variations in the mode of
genetic transmission.
The more commontypes of
VWD(Types I, !IA, and IIB) show an autosomal
dominant inheritance.
Type I VWD,the most common subtype, is the result of a quantitative
defect in the amount of von Willebrand factor
present in plasma and is secondary to an absolute
decrease in the amount of immunologically detectable factor VIII antigen.
Multimer formation is
normal. Because the absolute quantity of antigen
is decreased, there is a proportional decrease in
ristocetin cofactor activity and in the amount of
factor VIII procoagulant activity.
The latter is
presumably secondary to lack of available von
Willebrand factor for complexing and carrying the
procoagulant molecule. Platelet von Willebrand
factor is normal in quantity and multimer formation (Ruggeri et al. 1978, Zimmermanand
Ruggeri 1982). Type II VWDis characterized by
an absence of large multimers of von Willebrand
factor in plasma. In type !IA large multimers
are absent from both plasma and platelets
(Ruggeri and Zimmerman1981, Zimmermanand
Ruggeri 1982) and this absence is thought to
reflect a defect in multimer assembly (Zimmerman
and Ruggeri 1982). In type IIB , high molecular
weight multimers are absent from plasma but present in platelets (Ruggeri and Zimmerman1980,
1981). The von Will ebrand factor of type I IB is
hyperresponsive to ristocetin
leading to the
hypothesis that the decrease in plasma multimers
is secondary to increased binding of an abnormally avid von Willebrand factor to platelets and
tissue sites (Zimmermanand Ruggeri 1982). Type
III VWD
is the rarest type. This group contains
the autosomal recessive forms of VWD. Affected
individuals are severe bleeders and von
Willebrand factor levels · in homozygotes and
double heterozygotes may be undetectable in
plasma, platelets,
or endothelial cells,
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IIB, and III VWD
as compared to type I. The difference in reactivity did not correlate with von
Willebrand factor levels as reflected in the
ristocetin cofactor activity assay. Turitto et
al. (1983) eliminated the contribution of
spreading to the adhesive process by chelating
cations with EDTAand demonstrated a reduced
attachment phase to chymotrypsin-treated subendothelium in VWD
as compared to normal. These
findings suggest a role for high molecular weight
multimers of von Willebrand factor in both
attachment and spreading on subendothelium at
appropriate shear rates.
It appears well established that one can no
longer envision adhesion as a simple process;
adhesion clearly involves multiple complex steps
including attachment, cellular activation, granule release and spreading (Allen et al. 1979,
Turitto and Baumgartner 1982). v/hile our
understanding of the role of von Willebrand factor in adhesion to subendothelium has grown enormously in the past ten years, the factors which
modulate the subsequent activation steps such as
granule release and spreading are not yet worked
out. Scanning electron microscopy is becoming an
increasingly important tool in evaluating ~echanisms which control platelet activation and
spreading on surfaces.

BSS platelet membranes. Nachmanet al. (1977)
suggested that glycoprotei n I (GP I) comple x
mediates ristocetin aggregation.
Nurden and Caen
(1976, 1977), George et al. (1981), and Jamieson
et al. (1979a) subsequently confirmed the defect
in GP I complex in BSS platelets.
The resolution
of GP I compl ex into its component glycoprotei ns by
two dimensional gel electrophoresis
(Nurden et al.
1981, Peterson 1982) has allowed specific identification
of GP Ib(Mr 139,000. pl 6.36) as the
missing membrane component of BSS platelets.
Glycocalycin (GP Is),a macropolypeptide associated
with the GP I complex, has also been reported
absent from BSS platelets (Jamieson et al. 1979b).
Thus, a relationship between glycocalycin and the
missing GP lb has been suggested (Hagen et al.
1980). An antibody isolated from a transfused BSS
patient inhibited ristocetin and bovine factor
VIII aggregation of normal platelets as well as
platelet adhesion to subendothelium (Tobelem et
al. 1976). In addition, immunoprecipitation of
platelet membrane proteins with this antibody
brought down a 155,000 molecular weight component
(Degos et al. 1977) providing further evidence
that the membrane glycoproteinGP Ibmissing in BSS
is required for von Willebrand factor mediated
functions.
While reports on the BSS platelet response to
thrombin have been inconsistent,
at least two
laboratories
(Ganguly 1977, Jamieson and Okumura
1978) have demonstrated reduced numbers of thrombin binding sites and defective thrombin aggregation.
Okumura et al. (1978) postulate that
thrombin binds to a specific sequence in GP Is.
Recently Nurden and Dupuis (1981) have reported
the absence of a band corresponding to GP V. This
required labelling techniques that were more sensitive than those previously used to det ect GP I
abnormalities.
The lack of GP Vmay be responsible
for the altered response to thrombin reported in
some BSS patients as this glycoprotein is a
substrate for thrombin. Clementson et al. (1982)
have confirmed the absence of GP lb and GP V and
have in addition demonstrated a deficiency of a
low molecular weight glycoprotein, GP 17.
Kunicki and Aster (1978) using a 51cr-lysis
assay found that BSS platelets were not destroyed
by quinine/quinidine dependent antibodies, and
postulated that the receptor for these drugantibody complexes is deleted in BSS platelets.
Van Leeuwen et al. (1982) using a platelet suspension immunofluorescence test demonstrated that
drug induced antibodies require the Fe portion of
the molecule to bind to platelets.
They further
showed that although these antigen-antibody
complexes didn't produce lysis of BSS platelets,
some of the antibodies did bind to BSS platelets
while others didn't.
This suggests that the Fe
receptor for drug dependent antibodies is not
necessarily absent in BSS platelets but may be
altered in such a way as to prevent subsequent
lysi s.
The major functional abnormality in BSS is a
defect in adhesion. Adhesion to rabbit subendothelium is defective in both VWD(Tschopp et al.
1974) and BSS (Weiss et al. 1973, 1978, Caen et
al. 1976); Weiss et al. (1974, 1978) propose that
the initial contact or attachment phase of adhesion is defective in BSS. Zucker et al. (1977)
and Moake et al. (1980) have demonstrated defec-

The Bernard Soulier S ndrome BSS
The Bernard Soulier Syndrome BSS) is an autosomal recessive bleeding disorder characterized by
variable degrees of thrombocytopenia, a prolonged
bleeding time, and giant platelets on peripheral
smear (Bernard and Soulier 1948). The bleeding
time and clinical symptoms are out of proportion
to the thrombocytopenia suggesting an intrinsic
platelet defect (Caen et al. 1976). Additional
laboratory characteristics
include a normal clot
retraction,
defective prothrombin consumption, and
diminished binding of coagulation factors V, VIII
and XI to BSS platelets
(Grottum and Solum 1969,
Walsh et al. 1975). Aggregation of BSS platelets
with ADP, epinephrine, and collagen is normal
(Bithel l et al. 1972, Weiss et al. 1974, Caen et
al. 1976). Indeed, the rate of ADP-induced aggregation has been reported to be accelerated
(Bithell et al. 1972). However, BSS platelets
are not aggregated by ristocetin
(Howard et al.
1973a, Caen and Levy-Toledano 1973) (Figure 9A) or
bovine factor VII I (Weiss et al. 1974, Caen et al.
1973, 1976). In contrast to von Willebrand's
disease where defective ristocetin aggregation is
corrected by replacing the missing von Willebrand
factor, normal plasma containing von Willebrand
factor does not correct the defective ristocetin
aggregation of BSS (Caen and Levy-Toledano 1973,
Howard et al. 1973b, Firkin et al. 1974). Based
on these observations, it has been suggested that
a membrane receptor for the von Wille~rand factor
might be missing in BSS platelets.
Grottum and
Solum (1969) were the first to describe a platelet
membrane defect in BSS when they demonstrated
altered electrophoretic
mobility and decreased
membrane sialic acid content.
The decreased
sialic acid may be responsible for the shortened
survival of BSS platelets
(S Murphy 1972). Nurden
and Caen (1975) extended these observations
demonstrating deficient PAS staining of the glycoprotein I complex on SOS-PAGE
gels of isolated
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Figure 9 A-D. Bernard Soulier Syndrome (BSS). A:
Typical aggregation patterns.
B: TEMofsectioned BSS platelets.
C: SEMof
EDTA-anticoagulated BSS platelets in suspension.
D: SEMof adherent spread platelets from BSS
hetero zygote on carbon-formvar surface; contact
time 60 min. Aggregation curves in A demonstrate
characteristic
isolated absence of ristocetin
aggregation.
By conventional TEM(B) of sectioned
BSS platelets,
the only abnormality noted consistently is the presence of large platelets with
a corresponding increase in normal appearing granules. By SEM, EDTA-anticoagulated BSS platelets
in suspe nsion (C) are enlarged as compared to normal platelets (insert).
Note that EDTAinduces
sphering of both BSS and normal platelets.
SEMof
adherent and spreading platelets from BSS heterozygote (the mother of 2 affected siblings) shows
the giant size of occasional platelets
interspersed among normal sized platelets.
The
small tear in the membrane near the granulomere is
an artefact.
Eleven percent of this BSS
heterozygote's platelets were enlarged (>3.5 µm)
by light microscopy. In addition, 10% of her
spread forms were large (>12.5 µm). Bars= 1
micrometer.
tive binding of radiolabelled van Willebrand factor to BSS platelets.
These data suggest that,
under the appropriate flow conditions, adhesion of
platelets to subendothelial structures is mediated
by van Willebrand factor via membrane glycoprotein
I b/1 s.
Morphologic studies are of particular interest
in BSS, since giant platelets on smear are a
diagnostic feature of the disorder (Figure 9A-D).
Mean platelet diameters as measured on peripheral
smears demonstrate consistently enlarged platelets
in several reported kindred: 3.2-3.4 µm
(N=l.83+0.16) (Weiss et al. 1974), 3.09-4.44 µm
(N=2.13+0.02) (George et al. 1981) and 3.5-3.7 µm
(N=l.5-2.4) (Bithell et al. 1972).
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In contrast, Frojmovic et al. (1977, 1978)
have measured BSS discoid platelets and found them
to be of near normal size.
These authors found
that induction of sphering produced BSS platelets
that were disproportionately
larger than normal
sphered platelets
(Frojmovic and Milton 1982)
(Figure 9C). They cone l uded that a hypervol umetri c shape change occurs following stimulation and that the giant appearance of BSS
platelets in smears reflects abnormal membrane
behavior during preparation of blood films
(Frojmovic and Milton 1982). Evagination of an
excessive internal membrane system has been
suggested as a mechanism. Lusher and Barnhart
(1977), however, found markedly enlarged BSS platelets by TEM,and we have made similar observations on BSS platelets in directly fixed buffy
coats (unpublished observations).
Other evidence
of altered membrane reactivity has been reported
by Bithell et al. (1972) and Walsh et al. (1975)
who demonstrated absent ADP-induced shape change
in some of their BSS patients; this finding has
not been confirmed in other affected kindred (Caen
et al. 1973, Howard et al. 1973a). However, Caen
et al. (1973) demonstrated that shape change takes
longer to occur in BSS platelets which may explain
the divergent observations on its presence by
other investigators.
Ultrastructural
studies have described a
variety of inconstant changes including disorganized microtubules, granule deficiencies,
prominence of the OCSand DTSand increased vacuoles.
Some platelets have been described as having a
Swiss cheese appearance.
In general, however,
there are no characteristic
ultrastructural
features of the BSS platelet revealed by
transmission electron microscopy other than the
large size and a proportional increase in granules
(White 1982, Maldonado et al. 1975, Mattson et al.
1983) (Figure 9B). Chevalier et al. (1979) have
demonstrated an abnormality in distribution
of
membrane associated particles (MAPS)as visualized
in replicas of freeze fractured platelets.
Rather
than an equal and random distribution
of MAPSon
both exoplasmic (E) and protoplasmic (P) faces of
the bil i pid membrane as seen in the normal, the
BSS platelet had a greater concentration of particles on the protoplasmic face. We have recently
reported that BSS platelets in native plasma are
normally reactive to a formvar surface in a nonflow system, demonstrating a rate of spreading
comparable to or slightly greater than that of
controls (Ma'ttson et al. 1984). In addition fully
spread platelets from both homozygotes and heterozygotes demonstrated heterogeneity of size with
giant spread forms representing 22-44% of homozygote platelets and 0-10% of heterozygote platelets
(Figure 9D). Despite the abnormal size of a large
percentage of BSS spread platelets,
cytoskeletal
architecture
in both large and normal sized BSS
platelets,
as revealed by detergent extraction of
whole mounts for TEM,was identical to normalsized control platelets.

Schwendener (1942) demonstrated that a prolonged
bleeding time and isolated rather than aggregated
platelets on peripheral smear were further characteristics
of this disorder.
The main functional
defect is an impairment of platelet aggregation
(~/eiss 1975). Primary wave aggregation is absent
in response to ADP, epinephrine, collagen, serotonin, and noradrenalin (Hardi sty et al. 1964, Caen
et al. 1966, 1972, Lusher et al. 1977) (Figure
lOA).
Early studies on the pathophysiology of
Glanzmann's thrombasthenia (GT) implicated deficiencies in various platelet enzymes (Gross 1961,
Karpatkin and Weiss 1972, Moser et al. 1968) but
consistent abnormalities have not been reported.
Marcus and Zucker-Franklin (1964) and Caen et al.
(1966) independently suggested that a primary
membrane abnormality was responsible for the
aggregation defect seen in these patients.
However, direct evidence for such a defect was not
found until the seventies when a decrease or
absence of the externally exposed membrane glycoprotein complex GP IIb-IIIa was described by
Nurden and Caen (1974) and confirmed by Phillips
et al. ( 1975, 1977) and Peterson and 11ehring
( 1981). It has been demonstrated that thrombasthenic platelets
frequently lack fibrinogen
(Caen et al. 1966, Nachman1966, Nachmanand
Marcus 1968) and fail to bind fibrinogen normally
following stimulation by ADP(Pfueller and Firkin
1978, Bennett and Vilaire 1979), suggesting that
the fibrinogen receptor may be GP IIb-Illa.
Complexing of GP!Ib-lllarequires
calcium
(Jennings and Phillips 1982, Pidard et al. 1982).
McEver et al. (1983), using a monoclonal antibody
with specificity for the !lb-Illa complex but not
to either I lb or I I I a al one, have demonstrated
equal antibody binding to resting and stimulated
platelets.
This suggests that !lb and IIIa do not
exist as discrete and separate glycoproteins in
the resting platelet membrane but are complexed in
both the resting and stimulated platelet.
The
binding of fibrinogen mediates aggregation by a
mechanism not as yet worked out although various
possibilities
including direct bridging of adjacent platelets by fibrinogen have been suggested.
In addition to lack of fibrinogen, deficiency
of alpha-actinin has been detected in GT patients
(Gerrard et al. 1979) suggesting that the
GP IIb-lIIa complex may be bound to the platelet
cytoskeleton via this protein.
In addition, the
platelet antigen p1Al has been shown to be associated with GP I Ila (Kunicki and Aster 1979) and
patients with thrombasthenia have variable deficiencies in p1Al (Kunicki and Aster 1978). De
Gaetano et al. (1977) suggest from data on defective GT fibroblast retraction in culture that the
abnormality in cellular binding of fibrin/
fibrinogen might not be limited to platelets and
might be responsible for the defective late wound
healing observed at the skin biopsy site in their
donor GT patient.
More recently normal monocyte
membranes have been reported to contain GP
IIb-l!Ia but no data on monocytes from GT patients
was reported (Gogstad et al. 1983). No comparable
defect in red cell glycoproteins has been detected
(George et al. 1980).
Glanzmann's thrombasthenia has been recognized
in both sexes. Based on a lack of significant
clinical symptoms in parents of affected individuals and the frequency of consanguinity
in some

Glanzmann's Thrombasthenia (GT):
Thrombasthenia is a rare disorder of platelet
function first described by Glanzmann in 1918. It
now appears that the original patients were a
heterogeneous group who had in commonnormal or
near normal platelet counts but defective clot
retraction.
Naegeli (1931) and Fonio and
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Figure 10 A-E. Glanzmann's thrombasthenia ill..h_
A: aggregation patterns.
Band C: Transmission
electron micrographs of resting and ADPstimulated
GT platelets respectively.
D: Scanning electron
micrograph of adherent GT platelets on a carbonformvar surface; contact time 60 min. E: TEMof
whole mount preparation of adherent GT platelets
on carbon-formvar; contact time 60 min. In A the
characteristic
absence of aggregation in response
to ADP, collagen, and epinephrine is seen. TEMof
unstimulated GT platelets show no abnormalities
(B). ADPstimulated GT platelets (C) are able to
undergo shape change (sphering and centralization
of granules) in response to 2 x 10-6 M ADPdespite
inability to aggregate.
In contrast, GT platelets
do not spread normally on a carbon-formvar surface
(D and E). By SEM(D) and TEM(E), pseudopod formation is absent or abortive and spreading is not
seen. Bars = 1 micrometer.
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of the described affected families, an autosomal
recessive inheritance has been proposed (Caen et
a 1. 1966).
Bleeding, which varies in severity and can be
life threatening, usually begins in early life but
tends to decrease with age. The bleeding is
characterized by mucosal and cutaneous purpura.
The diagnostic laboratory features are a normal
platelet count, prolonged bleeding time, dimi376
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nished or absent clot retraction and markedly
diminished primary wave aggregation (Weiss 1975).
Regardless of the method used, aggregation by ADP,
epinephrine, serotonin (5-hydroxytryptamine),
thrombin, and collagen is defective (Hardisty et
al. 1964, Caen et al. 1966, 1970, 1972, Zucker et
al. 1966, Cronberg et al. 1967, 1971).
Thrombasthenic platelets aggregate in response to
ristocetin in the presence of adequate factor VIII
and to bovine fibrinogen (presumably due to the
presence of bovine factor VIII) (Weiss 1975).
Despite the inability to aggregate to all concentrations of ADP, thrombasthenic platelet
membranes bear the ADPreceptor (Bennett et al.
1977) and demonstrate the ability to change shape
following ADPstimulation (Zucker et al. 1966)
(Figure lOC). Platelet release of ADPand PF4 are
normal in response to collagen and thrombin
(Kubisz et al. 1971, Caen 1972, Weiss and Rogers
1973) but defective in the presence of ADPand
epinephrine (Zucker et al. 1966, Caen et al. 1970,
Cronberg et al . 1967). Whi 1e the aggregation
defect appears well established, thrombasthenic
platelets show variable defects in adhesion
depending on the method and substrate tested.
In
vivo platelet adhesion, as measured by the method
of Borchgrevi nk, is decreased (Borchgrevi nk 1961).
Adhesion of thranbasthenic platelets to collagen
has been reported as normal or near normal
(Balleisen et al. 1977, Caen 1972, Zucker et al.
1966) in some patients while defective interaction
with collagen has been reported in other GT
patients (Balleisen et al. 1977), with abnormal
adhesion, defective pseudopod formation and absent
spreading. Adhesion of GT platelets to subendothelium and to chymotrypsin-exposed collagen
fibrils is reduced liith absent platelet thrombi.
Examination of adherent GT platelets by TEM
demonstrated centralization
of filaments,
s phering, and decrease in granules suggesting that
the contractile wave and release had occurred
(Baumgartner et al. 1977). Platelet retention in
a glass bead column is often markedly reduced
(Salzman 1963); this has been attributed to the
defect in aggregation since this test assesses
both adhesion and aggregation.
Platelet adhesion
and spreading on a glass slide is absent or
markedly reduced (Caen et al. 1966, 1972) as is
adhesion to formvar in a non-flow system (Lusher
and Barnhart 1977, Lusher et al. 1977).
By light microscopy of stained smears the only
defect appreciated is the lack of aggregation; no
abnormality has been noted in individual platelets.
Electron microscopy of thin sectioned
unstimulated GT platelets reveals essentially normal ultrastructure
(Lusher and Barnhart 1977,
Boisseau et al. 1976, Caen et al. 1966) (Figure
lOB). In ADPstimulated GT platelets,
a contractile wave can be appreciated as granules and
microfilaments condense centrally.
In contrast to
normal ADPaggregates in which each compact
granule/microfilament mass is oriented toward the
center of the aggregate, in GT platelets the
contractile wave is oriented to the center of each
unaggregated platelet (Gerrard et al. 1979)
(Figure lOC).
Morphologic abnormalities in adhering GT platelets have been described using a variety of

techniques.
Rosenstein et al. (1981) have
demonstrated defective spreading on a siliconized
glass slide by DIC microscopy. Failure to interact
with fibrin strands was also noted. Lusher and
colleagues (Lusher and Barnhart 1977, Lusher et
al. 1977) using contact activation and adhesion to
formvar to evaluate platelet membrane reactivity
and viewing the reacting platelets by either SEM
or TEMhave demonstrated a decrease in adhesion
after 8 minutes of exposure to formvar. Pseudopod
formation was abnormal and subsequent spreading
defective (Lusher and Barnhart 1977, Lusher et al.
1977). Adherent platelets demonstrated sphering
with convoluted surface contours.
In a similar
test system using an extended period of exposure
to the formvar surface, we have also observed
decreased numbers of attached platelets, defective
pseudopod formation and total absence of spread
forms even after 60 minutes of contact (Figure
lOD,E).
The defective adhesion and spreading on
foreign surfaces demonstrated in GT platelets in
non-flow systems suggest a role for the missing
GP IIb-IIIa in platelet attachment and spreading.
This possibility is further supported by observations that fibrinogen coating of substrates
enhances platelet adherence (Packham et al. 1969,
Zucker and Vroman1969). Since GP IIb-IIIa is the
putative fibrinogen receptor, platelet adhesion to
foreign surfaces may be mediated at least in part
through GP IIb-IIIa interaction with a fibrinogen
coat. It must also be considered that the defect
in spreading may not be directly related to the
missing membraneglycoproteins but may be the
result of defective adhesion-induced release of
cofactors required for spreading.
NewDirections
The importance of pl atel et membrane receptors
in adhesion and aggregation reactions both as
binding sites for agonists that initiate the platelet response and as final effector sites for
binding to molecules that directly mediate adhesion and/ or aggregation cannot be denied. SEMhas
played a major role in increasing our understanding of membraneevents during platelet activation.
Use of specific labeling techniques with visible
probes has proved an exciting recent development
for study of receptor mobility, orientation, and
relationship to localized subcellular structures
such as membranesystems (OCS, DTS), and cytoskeletal components. Nurden et al. (1980) used gold
spheres bound to lectins to demonstrate lectin
binding sites on washed, fixed, discoid (resting)
platelets.
Wheat germ agglutinin (WGA)receptors
were seen scattered over the platelet surface and
in the rare pseudopod present.
Concanavalin A
(conA) binding could be seen by TEMbut not SEM.
The difference in SEM/TEM
visualization is
unexplained; the authors suggest that perhaps conA
receptors in the resting platelet are in crygtic
sites inaccessible to Au particles of 12-50 A
size. SEMshowed an even distribution of bound
WGA,and by double labeling TEMstudies with gold
particles of two different sizes, WGA
and conA
distributions
were seen to be separate.
These
immunolabelling studies correlate with biochemical
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data demonstrating that conA binds to a major
membrane GP of 100,000 molecular weight (Nachman
et al. 1973) while WGA
binds to 2 different glycoproteins of molecular weight s 150,000 and
210,000 respectively (Nachman et al. 1977).
While this study specifically
restricted
itself to the unstimulated platelet,
other surface
labelling studies have examined receptor mobility
following stimulation.
Furlan et al. ( 1981) examined the distribution
of colloidal gold complexed
to low molecular weight oligomers of bovine factor
VIII on platelet surfaces using both SEMand TEM.
On unfixed platelets the gold-factor VIII probe
was capable of inducing aggregation, and the stimulated platelets showed random distribution
of
the probe on the surface with greatest binding to
platelets that appeared stimulated or damaged by
TEM. If platelets were fixed first, factor VIII
binding appeared most concentrated on pseudopods.
This work suggests receptor site redistribution
with stimulation.
In a slightly different
approach, Polley et al. (1981) have used immunoelectron microscopy with ferritin
and hemocyanin
labels on intact platelets followed by lysis and
examination of resultant isolated membranes by TEM
to examine membrane glycoprotein distribution
in
unstimulated and thrombin-stimulated platelets.
They found random distribution
of both GP !lb and
GP Illa in unstimulated platelets while GP lb was
present in small clusters.
Thrombin stimulation
produced large mixed clumps of GP Ilb and GP Illa
and separate large clusters of GP lb.
Barnhart and Robinson (1975) used latex probes
couple d with antibodies to platelet factor 3 (PF3)
and fibrinogen to demonstrate their distribution
before and after thrombin stimulation.
By this
technique thrombin activated platelets
demonstrated significantly
more PF3 in the
membrane surface than unactivated platelets.
Fibrinogen was slightly increased on the platelet
surface after thrombin stimulation but more important was the observation that fibrinogen was concentrated at the platelet periphery and along
pseudopods rather than randomly dispersed. In more
recent studies, using an antibody to factor VIII
antigen covalently linked to a latex probe, Lusher
and Barnhart (1977) demonstrated by SEMthat les s
binding occurs to VWD
platelets than to normal
platelets,
suggesting a decrease in surface-bound
factor VIII on VWD
platelets.
Albrecht and Lewis (1982) presented work on
mapping contact activation-induced
changes in
membrane receptors for fibrinogen, fibronectin and
thrombospondin using gold-protein beads and gold
immunobeads.
This new approach will allow investigators to
use SEMto identify functional defects in receptors in patients who have antigenically normal
amounts of receptor present.
With the development
of monoclonal antibodies to mediator proteins such
as VWFand fibronectin and to specific platelet
membrane components, the future will surely see
the "mapping" of platelet functional sites.

mation der ived is limited and does not allow one
to distinguish etiologies.
A more important
application of correlative SEM/TEM
in the diagnosis of platelet dysfunction is the observation of
platelet reactivity to aggregating agents or activating surfaces.
Under these circumstances SEM
and TEMcan serve as important adjuncts to the
clinical assessment of platelet function.
It must
be emphasized that because three dimensional
changes in form may be the result of severa l different internal events, maximuminformation is
obtained when SEMand TEMare used together.
Using correlative SEM/TEM,the ability of platelets to undergo the normal physiologic responses
of adhesion, spreading, pseudopod formation, granule release, aggregation, and internal contraction can be assessed ultrastructurally.
With the
use of visible probes, future mapping of membrane
receptors for agonists and inhibitors and membrane
sites mediating adhesion and aggregation will
undoubtedly be added to our diagnostic capabilities and will allow more precise documentation of
those platelet disorders associated with acquirerl
and inherited membrane abnormalities.
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Discussion with Reviewers

However, in the correlative
SEM/TEM
studies
illustrated
in this review which demonstrate the
morphologic changes acompanying platelet
aggregation (Figures 4 and 5), it l'las necessary to
examine separate aliquots from the same aggregometer sample. This was necessary because the TEM
samples were embedded and sectioned, while the SEM
samples were of whole cells.
Our method of preparing aliquots of the same sample for SEMand TEM
have been previously published in detail (Mattson
et al . 1977).

D.A. Walz: One of the major unanswered questions
in platelet release reactions is the process of
degranulation.
Have you any SEMor TEMdata which
readily supports one type of mechanism, say granule membrane fusion, over alternative
hypotheses,
such as granule membrane disintegration
or
release?
Author: To my knowledge, there is no morphologic
data in the literature
which definitively
distinguishes
between platelet granule release by
a mechanism of membrane fusion versus a mechanism
of membrane dissolution.
However, it seems
likely, drawing parallels
from other secretory
cells, that the process probab ly includes fusion
of granule membranes with membranes of the open
canalicular system (OCS) with subsequent rupture
of the fused membranes and release of granule contents into the OCS. In support of this thesis,
White (1973) has demonstrated granule contents
within the OCSfollowing poly-L-lysine stimulation
of platelets.

D.A. Walz: One of the most exciting extensions of
SEMis its application to platelet mapping. Do you
envision these procedures as ult i mately being
capable of resolving specific receptor sites, such
as those for thrombin and collagen?
Author: Absolutely.
With the use of probes
visible at the resolving power of SEM, such as
colloidal gold, studies can be performed l'lith specific proteins such as collagen or thrombin
directly bound to the probe and the pattern of
attachment observed. Such studies have already
been reported for fibrinogen, fibronectin and factor VIII (see text).
Conversely, putative receptors can be mapped using specific antibodies to
individual membrane glycoproteins.
This approach
will be invaluable in the investigation
of the
mechanisms by which receptors modulating adhesion
and aggregation become available after stimulation
of the platelet by specific agonists.
In the area
of diagnostics,
it will allow rapid identification
of missing membrane receptors.

D.A. Walz: You have made reference to the process
of contractile
wave observations (Figure 4).
Could you elaborate on its definition and
,description;
is it a physical process observed by
SEM? The tenn implies one of continual motion,
particularly
directional
motion, and I am unclear
regarding its relationship
to SEM.
Author: Morphologic data supporting the concept
oTac:ontractile
wave comes primarily from TEM
observations of sectioned unstimulated and stimulated platelets.
Stimulus-induced shape change is
accompanied by the appearance of a dense central
matrix of contractile
filaments.
When aggregates
are formed, these masses of filaments are oriented
toward the center of the aggregate rather than the
center of each participating
platelet,
but when
aggregation is blocked, as it is in Glanzmann's
thrombasthenia, the filament matrix is found in
the center of each individual platelet.
Accompanying this condensation of cytoskeletal
filaments is the migration of platelet granules to
the cell center.
It is implied that the forces
for granule movement and their subsequent secretion is generated by the contraction of actomyosin
within the cytoskeleton.
Further morphologic data
for contraction of the cytoskeleton comes from
studies of isolated cytoskeletons from thrombintreated platelets.
Jennings et al. (1981)
observed that the shell of actin filaments, which
forms around the centralized granules in thrombin
stimulated platelets,
contracts from a diameter of
2.1 µm to 1.5 µm.
D.A. l·lalz: You make reference to seeing similar
structures by SEMand TEM. Is it possible to go
from one procedure to the other on the same specimen or is the reference more general in that it
refers to similar regions in different platelets?
Author: It is possible to examine whol e mount
preparations of adherent platelets
first by TEM
and then, after appropriate coating with a hi ghly
conductive element such as gold, to examine the
identical eel ls by SEM. The use of "finder grids"
simplifies identification
of specific cells.
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